What is meant by Thrombotic Microangiopathy (TMA)?

Similar documents
Hemolytic uremic syndrome: Investigations and management

DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)

Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016

* Renal insufficiencies

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch

Renal failure and thrombocytopaenia? Don t forget TTP/HUS. Jonathan Wala Nephrologist

A 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis).

Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura

Primary causes: Complement dysregulation (50% of non-shiga toxin-producing E. coli ) Secondary causes:

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI CLINICAL RESEARCH CENTER ALDO E FOR CELE RARE DACCO DISEASES ALDO E CELE DACCO

Supplementary Appendix

Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

TMA in HUS and TTP: new insights

1. INSTRUCTIONS 2. DEFINITION OF HUS

Thrombotic thrombocytopenic purpura: a look at the future

Haemolytic uraemic syndrome the story of a whodunit

Approccio morfologico alle microangiopatie trombotiche

Presentation Outline. Disease Background Previous research on platelet recovery rate Goal of our study Methods Results Limitations Conclusions

Microangiopatia trombotica (MAT) e Sindrome emolitico-uremica atipica (SEUa): Basi patogenetiche, inquadramento diagnostico e principi del

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Thrombotic Microangiopathies (TMA) / TTP/HUS/αHUS Pathology & Molecular. Genetics

R. Coward has documented that he has received cooperative grants from Takeda and Novo Nordisk

PLASMA EXCHANGE J MANION NEPEAN HOSPITAL

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D.

Atypical Hemolytic-uremic Syndrome with impending CKD PRESENTED BY DR.NADEEM AZAD JR-3,DEPARTMENT OF PEDIATRICS

Hemolytic Uremic Syndrome Epidemiological and Clinical Facts

The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry

Heme (Bleeding and Coagulopathies) in the ICU

Thrombotic thrombocytopenic purpura: 2008 Update

New insights in thrombotic microangiopathies : TTP and ahus

BBTS Advanced Clinical and laboratory case studies. Therese Callaghan

Year 2004 Paper one: Questions supplied by Megan

Soliris (eculizumab) DRUG.00050

Non-immune acquired haemolytic anaemias. Dr.Maysem

monoclonal gammopathy of undetermin Citation Rheumatology international, 33(1),

Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy

A 36 year old previously healthy female develops fever and ruising

HEME 10 Bleeding Disorders

Thrombotic Thrombocytopenic

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO

Index. Note: Page numbers of article titles are in boldface type.

Clinical Study Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic Syndrome

1) unexplained microangiopathic hemolytic anemia (Coombs negative anemia),

Paolo Gresele Dipartimento di Medicina, Sezione di Medicina Interna e Cardiovascolare, Università di Perugia

Specialised Services Policy: CP98 Eculizumab for Atypical Haemolytic Uraemic Syndrome (ahus)

Sara K. Vesely, James N. George, Bernhard Lämmle, Jan-Dirk Studt, Lorenzo Alberio, Mayez A. El-Harake, and Gary E. Raskob

DIAGNOSTIC CHALLENGES IN THROMBOTIC MICROANGIOPATHIES

PREGNANCY ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND ACUTE KIDNEY INJURY

Objectives. Thrombotic Thrombocytopenic Purpura (TTP) and ADAMTS13 Testing. Disclosure

Bleeding Disorders.2 MS Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD

THE MULTIPLE FACETS OF THROMBOTIC MICROANGIOPATHIES

Hemolytic uremic syndrome

Document Title: Hemostasis: Platelet and Coagulation Disorders. Author(s): Joseph H. Hartmann (University of Michigan), DO 2012

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

RaDaR Inclusion and Exclusion Criteria. Diagnosis Inclusion Criteria Exclusion Criteria. Alport Syndrome definite or probable

Guideline. Abstract. Key words

Pathology note 8 BLEEDING DISORDER

Accepted Manuscript. No more thrombotic thrombocytopenic purpura/hemolytic uremic syndrome please. Yeong-Hau H. Lien MD, PhD S (18)

Some renal vascular disorders

Symposium. Acute Kidney Injury with Thrombocytopenia. Lalitha A V*, Suryanarayana G**, Sumithra S***

Case report 24 th Summer School of Internal Medicine 2015

Introduction. Arif Asif 1 Ali Nayer 2 Christian S. Haas 3

Medical Policy. MP Eculizumab (Soliris) Related Policies None. Last Review: 01/24/2019 Effective Date: 04/25/2019 Section: Prescription Drug

Clinical study of 9 patients with acquired thrombotic thrombocytopenic purpura

Index. Note: Page numbers of article titles are in boldface type.

LAMA SHATAT TTP, ITP, DIC

Not So Benign Hematology Aplastic anemia, Paroxysmal Nocturnal Hemoglobinuria, atypical Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura

HUS and TTP Testing. Kenneth D. Friedman, M.D. Director, Hemostasis Reference Lab BloodCenter of Wisconsin, Milwaukee WI

Putting the Pieces Together. Anne Longtine MD Internal Medicine Residency, Maine Medical Center Maine ACP Annual Meeting Clinical Vignette 9/16/2017

Plasma exchange in thrombotic microangiopathies (TMAs) other than thrombotic thrombocytopenic purpura (TTP)

Hemolytic Uremic Syndrome

PNH ahus gmg. Dosing and Administration Guide

PNH ahus. Dosing and Administration. For Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic Uremic Syndrome (ahus) patients

Spectrum of complement-mediated thrombotic microangiopathies after kidney transplantation

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Case Studies. Scleroderma Renal Crisis or Thrombotic Thrombocytopenic Purpura: Seeing Through the Masquerade. Patient 1

Thrombotic microangiopathy and indications for therapeutic plasma exchange

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis

Corporate Medical Policy

Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome

Soliris and You. Your Guide To Living With ahus. INDICATION & IMPORTANT SAFETY INFORMATION FOR SOLIRIS (eculizumab)

Thrombotic Microangiopathy in the era of HIV

Thrombotic Microangiopathies

Behzad Poopak, DCLS PhD

Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency

HEL(L)P?! when extensive laboratory diagnostics are required. Madách Krisztina

Cigna Drug and Biologic Coverage Policy

Clinical Presentation and Follow-up of Eighteen Patients with Thrombotic Thrombocytopenic Purpura Received in: March 2007 Accepted in: 14/1/2010

Oncologic Emergencies. Angelina The, MD Lynn Cancer Institute August 30, 2016

Hematologic changes in systemic diseases. Chittima Sirijerachai

ahus A PATIENT S GUIDE To learn more about ahus, visit Copyright 2011, Alexion Pharmaceuticals, Inc. All rights reserved.

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis

Thrombotic Microangiopathy secondary to Malignant Hypertension presenting as acute Kidney injury-a Case Report

Most Common Hemostasis Consults: Thrombocytopenia

Transcription:

What is meant by Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (TMA) is a group of disorders characterized by injured endothelial cells, microangiopathic hemolytic anemia (MAHA), with its typical features of thrombocytopenia and schistocytes. Hemolytic Uremic Syndrome(HUS) & Thrombotic Thrombocytopenic Purpura (TTP) are the prototypes for TMA

Mechanism of TMA in TTP-HUS? Intraluminal Platelet Thrombosis Consumption of platelets Microangiopathic Hemolytic anemia Thrombocytopenia Hemolysis, Anemia, LDH & Bilirubin

Case Senario 1 A 35-year-old woman presented with an epileptic seizure five days after having a baby by Caesarean section. There was no previous history of epilepsy. She had been well throughout her pregnancy. She had two normal pregnancies without any complication. On examination her heart rate was 90 beats/min and regular and her temperature was 100.2 0 F. The blood pressure was 180/102 mmhg. She had a Glasgow coma score of 13/15. There was no evidence of a focal neurological deficit. Investigations are shown:

Hb 10 g/dl Sodium 137 mmol/l WCC 11 10 9 /l potassium 4.6 mmol/l Platelets 45 10 9 /l Urea 10 mmol/l Blood film Normochromic normocytic anaemia Creatinine 1.9 mg/dl Fragmented red cells; Bilirubin 1 mg/dl microspherocytes AST 34 iu/l PT 14 s (control 14 s) LDH 1530iu/l(NR 252-525iu/l) APTT 45 s (control 44 s) Alkaline 80 iu/l phosphatase Factor V level Normal Albumin 30 g/l Factor VII level Normal Urinalysis Protein ++ CT scan brain Normal What is the immediate management? a. Intravenous high-dose steroids. b. Platelet transfusion. c. Vitamin K. d. Plasma exchange with fresh-frozen plasma. e. Warfarin.

Case Senario 2 A 5-year-old male was admitted with a two-day history of blood-stained diarrhea. Three days after, he felt nauseous and generally unwell. On examination he had periorbital oedema and a blood pressure of 150/95mmHg. Investigations are shown Hb 8 g/dl WCC 13 10 9 /l Platelets 63 10 9 /l PT 13 s (control 13 s) APTT 34 s (Control 36 s) Blood film Sodium 138 mmol/l Potassium 5.9 mmol/l Creatinine 130µmol/l Urea 11mmol/l

What is the diagnosis? a. Nephrotic syndrome secondary to minimal Change glomerulonephritis. b. IgA nephritis. c. Haemolytic uraemic syndrome. d. Thrombotic thrombocytopenic purpura. e. Chronic pyelonephritis.

Thrombotic Thrombocytopenic Purpura (TTP) Traditionally, TTP is characterized by the pentad: MAHA, Thrombocytopenia, Neurologic symptoms, fever, and renal failure. The pathophysiology of TTP involves the accumulation of utra-large multimers of von Willebrand factors as result of decreased activity of the plasma protease ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13)

ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13)

Pathophysiology of TTP

TTP - Classification Autoantibodies Against ADAMTS13 Inherited deficiency of ADAMTS13 Acquired TTP (60% to 90% of the cases) Congenital TTP

Hemolytic Uremic Syndrome(HUS) HUS is loosely defined by the presence of MAHA and renal impairment. Most cases involve children <5 years of age, but adults also are susceptible. Diarrhea, often bloody, precedes MAHA within 1 week in majority of cases. Abdominal pain, cramping, and vomiting are frequent. Fever is typically absent. Neurologic involvement might occur.

Types of HUS Shiga Toxin Associated HUS STEC HUS (Shiga Toxin Producing E.coli e,g O157:H7) Shigella Dysenteriae. Neuraminidase Associated HUS S. pneumoniae Atypical HUS Factor H deficiency leads to alternative complement pathway activation with C3, normalc4, Autoimmune variant

Pathophysiology of TTP-HUS Intraluminal Platelet Thrombosis Consumption of platelets TTP ADAMTS 13 Thrombocytopenia Shiga toxin HUS Neuraminidase HUS Atypical HUS Toxin binds endothelium Alternative Complement Pathway

HUS Versus TTP HUS VS TTP Usually Children <5 years Tetrad MAHA Marked renal dysfunction Mild to moderate thrombocytopenia Mild CNS dysfunction Fever usually absent History of diarrhea or dysentery present Usually Adult Pentad MAHA Mild renal dysfunction Marked thrombocytopenia Severe CNS dysfunction Fever No history of diarrhea or dysentery

HUS Versus TTP HUS VS TTP Cause: Shiga toxin producing E.coli and Shigella dysenteriae. Neuraminidase producing S. pneumoniae. Atypical HUS (Complement dysregulation) Cause: Congenital deficiency or auto anti body to metalloproteinase ADAMTS13.

HUS Versus TTP Management: STEC HUS (Shiga toxin associated): supportive eg, fluid balance, dialysis, blood transfusion, Neuraminidase-HUS: Antibiotics and washed red cells. Atypical HUS: Eculizumab (A monoclonal ab to C5) Autoimmune variant: Plasmapheresis Management: Plasma exchange or plasmapheresis

Case Senario 1 A 35-year-old woman presented with an epileptic seizure five days after having a baby by Caesarean section. There was no previous history of epilepsy. She had been well throughout her pregnancy. She had two normal pregnancies without any complication. On examination her heart rate was 90 beats/min and regular and her temperature was 100.2 0 F. The blood pressure was 180/102 mmhg. She had a Glasgow coma score of 13/15. There was no evidence of a focal neurological deficit. Investigations are shown:

Hb 10 g/dl Sodium 137 mmol/l WCC 11 10 9 /l potassium 4.6 mmol/l Platelets 45 10 9 /l Urea 10 mmol/l Blood film Normochromic normocytic anaemia Creatinine 1.9 mg/dl Fragmented red cells; Bilirubin 1 mg/dl microspherocytes AST 34 iu/l PT 14 s (control 14 s) LDH 1530iu/l(NR 252-525iu/l) APTT 45 s (control 44 s) Alkaline 80 iu/l phosphatase Factor V level Normal Albumin 30 g/l Factor VII level Normal Urinalysis Protein ++ CT scan brain Normal What is the immediate management? a. Intravenous high-dose steroids. b. Platelet transfusion. c. Vitamin K. d. Plasma exchange with fresh-frozen plasma. e. Warfarin.

Answer d. Plasma exchange with fresh-frozen plasma.

Case Senario 2 A 5-year-old male was admitted with a two-day history of blood-stained diarrhea. Three days after, he felt nauseous and generally unwell. On examination he had periorbital oedema and a blood pressure of 150/95mmHg. Investigations are shown Hb 8 g/dl WCC 13 10 9 /l Platelets 63 10 9 /l PT 13 s (control 13 s) APTT 34 s (Control 36 s) Blood film Sodium 138 mmol/l Potassium 5.9 mmol/l Creatinine 130µmol/l Urea 11mmol/l

What is the diagnosis? a. Nephrotic syndrome secondary to minimal Change glomerulonephritis. b. IgA nephritis. c. Haemolytic uraemic syndrome. d. Thrombotic thrombocytopenic purpura. e. Chronic pyelonephritis.

Answer c. Haemolytic uraemic syndrome.